EUVIMEDEUVIMED entdecken
Open Access

Disease progression in idiopathic pulmonary fibrosis under anti-fibrotic treatment.

Aykut Cilli, Fatih Uzer

Sarcoidosis vasculitis and diffuse lung diseases · 13.09.2023 · 40 (3) · e2023034-e2023034

DOI: 10.36141/svdld.v40i3.14048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Sarcoidosis vasculitis and diffuse lung diseases, erschienen am 13.09.2023. Verfasst von Aykut Cilli und 1 weiteren Autor:innen. Beteiligte Einrichtung: Akdeniz University. acilli@akdeniz.edu.tr. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Idiopathic pulmonary fibrosis (IPF) is the most common progressive interstitial disease of unknown etiology. The course of disease is not possible to predict. Frequent monitoring using multiple assessments is important to evaluate disease progression. Currently, there is no consensus on how progression should be defined. Nintedanib and pirfenidone slow the progression of IPF, but the disease can progress even under anti-fibrotic treatment. The goal of this review is to examine and summarize the current data about IPF progression in patients who were on anti-fibrotic treatment. Also, we outline the limitations of the tests used for disease progression.

Schlagwörter

idiopathic pulmonary fibrosisdisease progressionantifibrotic therapynintedanibpirfenidoneinterstitial lung diseasedisease surveillance

Autor:innen und Institutionen

  • Akdeniz University. acilli@akdeniz.edu.tr.
  • Akdeniz university. uzerfatih@gmail.com.

Zitieren

APA

Cilli, A., & Uzer, F. (2023). Disease progression in idiopathic pulmonary fibrosis under anti-fibrotic treatment. Sarcoidosis vasculitis and diffuse lung diseases, 40(3), e2023034-e2023034. https://doi.org/10.36141/svdld.v40i3.14048

Vancouver

Cilli A, Uzer F. Disease progression in idiopathic pulmonary fibrosis under anti-fibrotic treatment. Sarcoidosis vasculitis and diffuse lung diseases. 2023;40(3):e2023034-e2023034. doi:10.36141/svdld.v40i3.14048

BibTeX
@article{Cilli2023,
  author = {Cilli, Aykut and Uzer, Fatih},
  title = {Disease progression in idiopathic pulmonary fibrosis under anti-fibrotic treatment},
  journal = {Sarcoidosis vasculitis and diffuse lung diseases},
  year = {2023},
  volume = {40},
  number = {3},
  pages = {e2023034--e2023034},
  doi = {10.36141/svdld.v40i3.14048}
}
Kostenlos starten →